Panel Discussion: Untangling the Future of Neuroimmunology Drug Development in the Wake of TREM2 Trial Results: To What Extent are Current TREM2 Models Fit For Purpose?
Time: 4:30 pm
day: Conference Day One
Details:
- Exploring how clinical validation of TREM2 will inform back translation and to what extent our current models still fit for purpose
- Navigating trial impact on preclinical model validation to better recapitulate neuroinflammatory pathology Evaluating the probable impact of inhibiting or stimulating microglia to reduce pathological neuroinflammation?
- How can we build on the next generation of neuroinflammatory targets, in vivo and in vitro models to more specifically and effectively target neuroinflammation?
